Ken Frazier Joins Former Merck & Co Colleagues At Eikon Therapeutics

Becomes Start-Up’s First Independent Board Member

 
• By Andrew McConaghie
  
Eikon Therapeutics
Eikon Therapeutics's platform can track real-time movements of proteins in living cells in the service of novel drug discovery. • Source: Eikon Therapeutics (McConaghie, Andrew)

More from Business

More from Scrip